Walking exercise + blood flow restriction

1 paper4 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Human trial1

Outcomes

Parkinson's disease

downin humans1

1 study

Walking exercise + blood flow restriction decreases Parkinson's disease in humans.
“and total UPDRS scores, with additional reductions in UPDRS Parts II-IV”
Human trialParkinson's disease8 weeksn = 8
Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)
European journal of applied physiology13 Aug 2026

Latest

1 in 12 months

European Journal of Applied Physiology13 Aug

Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)

Randomised trial in 24 peopleParkinson's disease

Paper

Walking exercise + blood flow restriction

Outcomes

Latest

Walking with blood flow restriction in Parkinson's disease: vascular, neurotrophic and functional outcomes: a randomized controlled trial (WALK-BFR-PD Trial)

Related